Institutional investors purchased a net $67.8 thousand shares of PRAN during the quarter ended December 2016. This may signal that the smart money is gaining interest in this company as the 1.59% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 8.6 Thousand shares of Prana Biotechnology Ltd